|
Back to Home » May 2020 News » Mayne Pharma launches BAC 300 capsules in the United States |
Mayne Pharma launches BAC 300 capsules in the United States |
May 22, 2020
ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg in the United States. Mayne Pharma received approval from the US Food and Drug Administration...
Source URL: https://www.prnewswire.com:443/news-releases/mayne-pharma-launches-bac-300-capsules-in-the-united-states-301064172.html
|
|
|
|
